期刊文献+

复发性卵巢癌的治疗进展 被引量:16

Recent advances in the treatment of recurrent ovarian cancer
下载PDF
导出
摘要 复发性卵巢癌的高发率及致死率一直是临床上的难题。根据复发性卵巢癌的定义、发病因素、诊断方法来不断探究对其有效的治疗方法是临床亟待解决的难题,结合患者的个人情况,是否行二次手术、如何确定化疗方案等问题仍然在不断地探索和实践中。另外,治疗新领域的开拓,如生物治疗、分子靶向治疗等新兴治疗方法已普遍被人们所接受,并积极运用于临床实践当中,已取得较好的治疗效果。 Recurrent ovarian cancer is a difficult problem of clinical medicine. Combined with the patient’s individual situation,how to determine whether secondary surgery,chemotherapy are studied. In addition,the new treatment,such as biological treatment,emerging treatments such as molecular targeted therapy has been widely accepted by people,and actively applied in clinical practice.
作者 张玉霞 王晶
出处 《现代肿瘤医学》 CAS 2016年第11期1837-1840,共4页 Journal of Modern Oncology
关键词 复发性卵巢癌 诊断 手术 放疗 生物治疗 分子靶向治疗 recurrent ovarian cancer diagnosis surgery radiotherapy biological therapy molecular targeted therapy
  • 相关文献

参考文献31

  • 1孙波,冯妍,朱哲,王柏清.CIK治疗对癌症患者免疫力影响研究[J].中国伤残医学,2014,22(6):171-172. 被引量:3
  • 2Werner Meier,Andreas du Bois,Alexander Reuss,et al.Topotecan versus treosulfan,analkylating agent,in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. Cancer . 2009 被引量:1
  • 3Kim HM,Lim J,Kang JS.Inhibition of human cervical carcinoma growth. International Journal of Immunopharmacology . 2009 被引量:1
  • 4Jonathan Berek,Peyton Taylor,William McGuire,L. Mary Smith,Birgit Schultes,Christopher F. Nicodem.Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer. Japanese Journal of Clinical Oncology . 2009 被引量:1
  • 5Garcia Agustin A,Hirte Hal,Fleming Gini,Yang Dongyun,Tsao-Wei Denice D,Roman Lynda,Groshen Susan,Swenson Steve,Markland Frank,Gandara David,Scudder Sidney,Morgan Robert,Chen Helen,Lenz Heinz-Josef,Oza Amit M.Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2008 被引量:1
  • 6Emens Leisha A,Silverstein Samuel C,Khleif Samir,Marincola Francesco M,Galon Jér?me.Toward integrative cancer immunotherapy: targeting the tumor microenvironment. Journal of translational medicine . 2012 被引量:1
  • 7Helen Heyerdahl,Cecilie Krogh,Jorgen Borrebaek.TREATMENT OF HER2-EXPRESSING BREAST CANCER AND OVARIAN CANCER CELLS WITH ALPHA PARTICLE-EMITTING (TH)-T-227-TRASTUZUMAB. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS . 2011 被引量:1
  • 8Eisenkop SM,Friedman RL,Spirtos NM.The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer . 2000 被引量:1
  • 9Miao H,Burnett E,Kinch M,et al.Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nature Cell Biology . 2000 被引量:1
  • 10Futagami M,Yokoyama Y,Mizunuma H.Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion. European Journal . 2011 被引量:1

二级参考文献37

共引文献14

同被引文献131

引证文献16

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部